Objective To summarize proceedings of a workshop convened to discuss the current state of
science in the disease of osteoarthritis (OA), identify the knowledge gaps, and examine the …

Osteoarthritis (OA) is one of the most debilitating diseases and is associated with a high
personal and socioeconomic burden. So far, there is no therapy available that effectively …

Introduction: Osteoarthritis is a disabling affliction, and disease-modifying osteoarthritis
drugs (DMOADs) would be highly desirable adjuncts to symptomatic relief as they may delay …

There are a variety of oral and topical pharmaceutical agents for the treatment of
osteoarthritis. To date there is no pharmacologic agent proved to prevent disease …

Introduction: Conventional medical therapies for osteoarthritis are mainly palliative in nature,
aiming to control pain and symptoms. Traditional intra-articular therapies are not …

Osteoarthritis (OA) is progressive joint disease characterized by joint inflammation and a
reparative bone response and is one of the top five most disabling conditions that affects …

Osteoarthritis (OA) is a chronic, progressive degenerative whole joint disease that affects the
articular cartilage, subchondral bone, ligaments, capsule, and synovium. While it is still …

Osteoarthritis (OA) is a painful and disabling disease that affects millions of people
worldwide. Symptom-alleviating treatments exist, although none with long-term efficacy …

Osteoarthritis (OA) is the most common form of arthritis. It is characterized by progressive
destruction of articular cartilage and the development of chronic pain and constitutes a …

Background Despite availability of international evidence-based guidelines for osteoarthritis
(OA) management, agreement on the different treatment modalities is lacking. Method A …